
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Author(s) -
Ravi Kumar,
Santa Ayyagari,
Senthil Rajappa,
Aleena Agarwal,
Sudha S Murthy
Publication year - 2020
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/ijmpo.ijmpo_165_18
Subject(s) - merkel cell carcinoma , medicine , malignancy , chemotherapy , radiation therapy , disease , dermatology , adjuvant radiotherapy , adjuvant , oncology , adjuvant chemotherapy , merkel cell , carcinoma , cancer , breast cancer
Merkel-cell carcinoma (MCC) is a rare skin malignancy seen in elderly males. It is a highly aggressive tumor with a poor prognosis. Surgery is the mainstay of treatment for localized disease with adjuvant radiation depending on the locoregional extent, while chemotherapy has a role in metastatic disease. Emerging data from treatment with immune checkpoint inhibitors look promising. We report a case of MCC in an elderly male diagnosed and treated with chemotherapy and radiation, with a review of the literature of this rare malignancy.